Two NIH-funded fellowship positions in the Sabaawy Lab at Rutgers Cancer Institute of NJ are available to study epigenetic polycomb signaling and tumor cell heterogeneity in either prostate cancer or brain cancer utilizing patient derived organoids, genome editing, single cell sequencing and immune humanized mouse models. The positions require strong skills in cancer molecular biology and immunology. By the completion of the project, the postdoctoral fellow will become proficient in genetic and immunological studies in humans and mouse models. A career development plan, mentorship committee and defined path for career progression will be provided.
Rutgers Cancer Institute of New Jersey (www.cinj.org) is an NCI-designated comprehensive cancer center with state-of-the-art research facilities including a precision oncology and clinical therapeutic programs, biobanking, CRISPR mediated genome editing, among many other core and support facilities. The cancer center is affiliated with Rutgers Biomedical Health Sciences (RBHS) and Robert Wood Johnson Medical School (RWJMS) and is located in the central New Jersey area in New Brunswick, with pleasant and affordable living area and easy access to the New York and Philadelphia metropolitan regions. We offer a competitive salary, comprehensive fellowship benefits, and career development support. CINJ and RWJMS are equal opportunity employers. Review of the applications will be on a rolling basis until the positions are filled.
To apply, please send a CV, one-paragraph statement of research experience/interests outlining either prostate cancer or brain cancer interest and a list of three qualified references (mentors) by email with either postdoc – Brain cancer or postdoc – Prostate cancer in the subject line to: email@example.com and firstname.lastname@example.org
or apply online at: